Rational Advisors’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-18,935
| Closed | -$2.28M | – | 307 |
|
|
2023
Q1 | $2.28M | Sell |
18,935
-23,200
| -55% | -$2.8M | 0.19% | 50 |
|
|
2022
Q4 | $4.84M | Hold |
42,135
| – | – | 0.4% | 28 |
|
|
2022
Q3 | $4.31M | Hold |
42,135
| – | – | 0.34% | 26 |
|
|
2022
Q2 | $4.28M | Buy |
42,135
+5,500
| +15% | +$558K | 0.31% | 27 |
|
|
2022
Q1 | $4.26M | Buy |
36,635
+15,700
| +75% | +$1.83M | 0.25% | 34 |
|
|
2021
Q4 | $2.38M | Buy |
+20,935
| New | +$2.38M | 0.15% | 54 |
|
|
2021
Q2 | – | Sell |
-35,135
| Closed | -$3.8M | – | 198 |
|
|
2021
Q1 | $3.8M | Buy |
35,135
+14,570
| +71% | +$1.58M | 0.7% | 27 |
|
|
2020
Q4 | $2.25M | Hold |
20,565
| – | – | 0.6% | 34 |
|
|
2020
Q3 | $2.29M | Buy |
20,565
+5,390
| +36% | +$600K | 0.98% | 20 |
|
|
2020
Q2 | $1.59M | Buy |
+15,175
| New | +$1.59M | 0.82% | 33 |
|